UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 23, 2006
Hydromer, Inc.
(Exact name of registrant as specified in its chapter)
New Jersey 0-10683 22-2303576
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
35 Industrial Parkway
Branchburg, N.J. 08876
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (908) 722 - 5000
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
( ) Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
( ) Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
( ) Pre-commencement communications pursuant to Rule 14-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
( ) Pre-commencement communications pursuant to Rule 13e-4(C) under the
Exchange Act (17 CFR 240-13e-4(c))
Item 8.01. Other Events
-----------------------
Press Release Announcing an Evaluation Phase on its Non-Drug Stent Coating, with
Unique Anti-Cell Mitosis Properties
EXHIBIT INDEX
Exhibit No. Description of Exhibit
----------- ----------------------
99.22 Press Release issued October 23, 2006
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Hydromer, Inc.
------------------------
Registrant
/s/ Robert Y. Lee
------------------------
Date October 23, 2006 Robert Y. Lee
---------------- Chief Financial Officer